RecruitingNCT07069673

Abbott Cephea Mitral Valve Disease Registry

Abbott Medical DevicesMultiple US sitesView on ClinicalTrials.gov

AI Description

The objective of this registry is to gather clinical data on symptomatic patients with mitral valve disease, including patients with mitral regurgitation, mitral stenosis, and mixed mitral valve disease. Data collected from this registry are expected to improve our understanding of the impact of correcting symptomatic mitral valve disease on clinical outcomes in patients that could be candidates for Transcatheter Mitral Valve Replacement and may also inform future regulatory or reimbursement submission strategies for the Cephea Mitral Valve System.

Report inaccurate information

Who can join
adult, older adult
Participants
1000
Expected completion
2028-12
Funded by
industry

Conditions studied

Mitral Annulus Calcification, Mitral Regurgitation, Mitral Stenosis, Mitral Valve (MV) Regurgitation, Mitral Valve Disease, Mitral Valve Replacement, Transcatheter Valve Replacement

What it measures

  • Primary Objective, The objective of the MVD Registry is to collect data on the progression of MVD patients considered for TMVR therapy to guide product development, regulatory submissions, and reimbursement planning, From enrollment to 2 years of follow-up

Centers Participating

These centers are participating in this study. Reach out to them directly to learn more.

Data Sources and Methodology

Registry entry updated 2026-09-10

Deciding whether to join a study is your choice, and you can ask a study team questions before you decide anything.

If you would rather we did it with you, call us on (656) 206-4686.